Yet, whether Tpr misregulation is a consequence of pathological protein aggregation in AD or rather contributes to the development is unknown and future experiments will address the underlying mechanism of Tpr regulation in NSPCs in AD. This evidence concerns the gene TPR and Alzheimer disease.